A Progressive Resistance Training Program in Patients With Haemophilia

October 15, 2018 updated by: Felipe Querol Fuentes, University of Valencia

The Impact of Progressive Resistance Training on Quality of Life in Patients With Haemophilia

This study evaluates the clinical impact of a progressive resistance training program in adults patients with haemophilia

Study Overview

Detailed Description

The training program aims improving muscular strength and endurance in the relevant muscles and joints (knee, elbow, ankle, shoulder and hip) in order to improve the quality of life in the patients.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Valencia, Spain, 46010
        • University of Valencia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • diagnosis of haemophilia A or B
  • willingness to exercise twice a week during the training program and to complete the pre- and post-program evaluations
  • approval by their hematologist to participate in the exercise program
  • age between 18 and 60 years
  • informed consent signed.

Exclusion Criteria:

  • the inability to attend exercise sessions at least twice a week for 6 consecutive weeks
  • non adherence to instruction on proper exercise technique
  • surgical procedures performed 6 weeks prior to or during the exercise program
  • participation in any other form of exercise, including rehabilitation, during the study; (5) changes in medication during the study
  • a major bleeding episode that posed a risk or prevented exercise
  • History of FVIII inhibitor (titer ≥ 0.6 BU [Bethesda unit]) or detectable FVIII inhibitors at screening (titer ≥ 0.4 BU)
  • Another haemostatic defect
  • Need for major surgery
  • Withdrawal of informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Training group
Each subject will participate in 2 sessions each week during 8 weeks, with 3 days of difference (rest) between the sessions.
Progressive resistance training program
Placebo Comparator: Control group
Usual daily activities
Usual daily activities

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Muscle strength
Time Frame: baseline and 8 weeks
For measuring the isometric knee flexion and extension, ankle plantarflexion and dorsiflexion strength and isometric elbow flexion and extension strength, a portable hand-held dynamometer will be used (Nicholas Manual Muscle Tester, Lafayette Instruments, Indiana, USA).
baseline and 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Timed Up and Go
Time Frame: baseline and 8 weeks

The Timed Up and Go test (TUG) is a simple test used to assess a person's mobility and requires both static and dynamic balance.

It uses the time that a person takes to rise from a chair, walk three meters, turn around, walk back to the chair, and sit down.

baseline and 8 weeks
Change in Haemophilia Quality of life questionnaire (A36 Haemophilia-QoL® )
Time Frame: baseline and 8 weeks
The Haemophilia-QoL questionnaire is a self-report modular instrument that assesses nine relevant HRQoL domains for patients with haemophilia (e.g. physical health, daily activities, joint damage, pain, treatment satisfaction, treatment difficulties, emotional functioning, mental health, relationships and social activity).
baseline and 8 weeks
Change in Bleedings
Time Frame: daily (during the 8 weeks of intervention)
Number of Bleedings During the study
daily (during the 8 weeks of intervention)
Change in viscoelastic properties (rectus femoris)
Time Frame: baseline and 8 weeks
Myoton Pro
baseline and 8 weeks
Change in sit-to-stand test
Time Frame: baseline and 8 weeks
The time taken for the participant to stand up and sit down from a standard 45 cm chair with arms three times, as quickly as possible, was measured.
baseline and 8 weeks
Change in Haemophilia Activities List questionnaire
Time Frame: baseline and 8 weeks

The Haemophilia Activities List questionnaire measures the impact of hemophilia on self-perceived functional abilities in adults.

It contains 42 multiple choice questions in seven domains:

Lying/sitting/kneeling/standing (8 items) Functions of the legs (9 items) Functions of the arms (4 items) Use of transportation (3 items) Self-care (5 items) Household tasks (6 items) Leisure activities and sports (7 items) The most important outcomes are the overall sum score and three component scores relating to upper extremity activities, basic lower extremity activities, and complex lower extremity activities. A domain score for each of the seven domains can also be calculated.

baseline and 8 weeks
Change in The Haemophilia Joint Health Score (HJHS)
Time Frame: baseline and 8 weeks
The HJHS measures joint health, in the domain of body structure and function (i.e. impairment), of the joints most commonly affected by bleeding in hemophilia: the knees, ankles, and elbows.The HJHS 2.1 provides a total score (higher score is worse; max=124), joint specific scores, and a global gait score.
baseline and 8 weeks
Change in Pain
Time Frame: baseline and 8 weeks
11-point numerical pain rating scale with higher score meaning higher pain
baseline and 8 weeks
Change in workability index
Time Frame: baseline and 8 weeks
workability index with single question
baseline and 8 weeks
Change in analgesics use (days/week)
Time Frame: baseline and 8 weeks
The number of days the participants used analgesics during the last week
baseline and 8 weeks
Change in Range Of Motion (ROM)
Time Frame: baseline and 8 weeks
elbow extensio/flexion, ankle dorsiflexion/plantar flexion and knee flexion/extension ROM with a goniometer
baseline and 8 weeks
Change in Kinesiophobia
Time Frame: baseline and 8 weeks
Tampa Scale of Kinesiophobia (TSK-11SV) used to assess changes in fear of movement
baseline and 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Felipe Querol-Fuentes, MD, PhD, University of Valencia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 24, 2017

Primary Completion (Actual)

June 25, 2018

Study Completion (Actual)

June 25, 2018

Study Registration Dates

First Submitted

May 18, 2016

First Submitted That Met QC Criteria

May 20, 2016

First Posted (Estimate)

May 24, 2016

Study Record Updates

Last Update Posted (Actual)

October 18, 2018

Last Update Submitted That Met QC Criteria

October 15, 2018

Last Verified

October 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Haemophilia

Clinical Trials on Normal daily activities

Subscribe